[
  {
    "sentence": "Associations with breast cancer free interval in treatment‐stratified analysis\nThe two common SNPs (MAF = 0.455), rs1877193 and rs6735923, were eQTLs for LY75 gene expression in breast tissue (Figure \n\n2f\n), and they were also in perfect LD (r\n2 = 1).",
    "figure_references": [
      {
        "figure_number": "Figure 2",
        "panel": "Panel f",
        "figure_key": "figure_2"
      }
    ]
  },
  {
    "sentence": "These 2 SNPs mapped upstream of LY75 on chromosome 2 (Figure \n\n3a,b\n) and had significant interaction with treatments (SNP rs1877193: HR: Exe/Ana = 0.45; SNP rs6735923: HR: Exe/Ana = 0.46; Table \n\nS5\n), indicating ~ 55% reduction in the hazard for a breast cancer event for patients carrying the variant genotype treated with exemestane compared with anastrozole.",
    "figure_references": [
      {
        "figure_number": "Figure 3",
        "panel": "Panel a",
        "figure_key": "figure_3"
      }
    ]
  },
  {
    "sentence": "ANOVA, analysis of variance; LCL, lymphoblastoid cell line; PCR, polymerase chain reaction; qRT‐PCR, quantitative real‐time polymerase chain reaction; SNP, single‐nucleotide polymorphism.The GPR160 SNP rs62293499 mapped downstream of GPR160 on chromosome 3p7, and the variant allele was associated with increased GPR160 expression (Figure \n\n2f\n).",
    "figure_references": [
      {
        "figure_number": "Figure 2",
        "panel": "Panel f",
        "figure_key": "figure_2"
      }
    ]
  },
  {
    "sentence": "The two common SNPs (MAF = 0.455), rs1877193 and rs6735923, were eQTLs for LY75 gene expression in breast tissue (Figure \n\n2f\n), and they were also in perfect LD (r\n2 = 1).",
    "figure_references": [
      {
        "figure_number": "Figure 2",
        "panel": "Panel f",
        "figure_key": "figure_2"
      }
    ]
  },
  {
    "sentence": "These 2 SNPs mapped upstream of LY75 on chromosome 2 (Figure \n\n3a,b\n) and had significant interaction with treatments (SNP rs1877193: HR: Exe/Ana = 0.45; SNP rs6735923: HR: Exe/Ana = 0.46; Table \n\nS5\n), indicating ~ 55% reduction in the hazard for a breast cancer event for patients carrying the variant genotype treated with exemestane compared with anastrozole.",
    "figure_references": [
      {
        "figure_number": "Figure 3",
        "panel": "Panel a",
        "figure_key": "figure_3"
      }
    ]
  },
  {
    "sentence": "The GPR160 SNP rs62293499 mapped downstream of GPR160 on chromosome 3p7, and the variant allele was associated with increased GPR160 expression (Figure \n\n2f\n).",
    "figure_references": [
      {
        "figure_number": "Figure 2",
        "panel": "Panel f",
        "figure_key": "figure_2"
      }
    ]
  },
  {
    "sentence": "The variant cell lines showed a reduction of LY75 expression in response to androstenedione exposure, whereas WT LCLs did not (Figure \n\n3c,d\n).",
    "figure_references": [
      {
        "figure_number": "Figure 3",
        "panel": "Panel c",
        "figure_key": "figure_3"
      }
    ]
  },
  {
    "sentence": "In contrast, WT expression did not change (Figure \n\n3c\n).",
    "figure_references": [
      {
        "figure_number": "Figure 3",
        "panel": "Panel c",
        "figure_key": "figure_3"
      }
    ]
  },
  {
    "sentence": "Of importance, exemestane did not change the expression patterns of LY75 in either WT or variant genotype LCLs (Figure \n\n3d\n).",
    "figure_references": [
      {
        "figure_number": "Figure 3",
        "panel": "Panel d",
        "figure_key": "figure_3"
      }
    ]
  },
  {
    "sentence": "The variant cell lines showed a reduction of LY75 expression in response to androstenedione exposure, whereas WT LCLs did not (Figure \n\n3c,d\n).",
    "figure_references": [
      {
        "figure_number": "Figure 3",
        "panel": "Panel c",
        "figure_key": "figure_3"
      }
    ]
  },
  {
    "sentence": "In contrast, WT expression did not change (Figure \n\n3c\n).",
    "figure_references": [
      {
        "figure_number": "Figure 3",
        "panel": "Panel c",
        "figure_key": "figure_3"
      }
    ]
  },
  {
    "sentence": "Of importance, exemestane did not change the expression patterns of LY75 in either WT or variant genotype LCLs (Figure \n\n3d\n).",
    "figure_references": [
      {
        "figure_number": "Figure 3",
        "panel": "Panel d",
        "figure_key": "figure_3"
      }
    ]
  },
  {
    "sentence": "Anastrozole, but not exemestane, regulates LY75 SNP‐dependent ERα/ERE binding\nTo determine whether the SNP‐ and AI‐dependent LY75 gene regulation was mediated by ERα, we first identified two EREs; 2 bp overlap with each other) located ~ 200 bp distant from the LY75 SNP rs1877193 based on ENCODE data (Figure \n\n3e\n).",
    "figure_references": [
      {
        "figure_number": "Figure 3",
        "panel": "Panel e",
        "figure_key": "figure_3"
      }
    ]
  },
  {
    "sentence": "We then performed ChIP assays with ERα antibody and found that the rs1877193 SNP (Figure \n\n3f\n) showed striking differential binding to the ERE that was located closest to the SNP, with greater binding for the variant SNP genotype in the presence of androstenedione, but less binding when additional anastrozole was present.",
    "figure_references": [
      {
        "figure_number": "Figure 3",
        "panel": "Panel f",
        "figure_key": "figure_3"
      }
    ]
  },
  {
    "sentence": "However, this differential binding pattern was not detected after exemestane treatment (Figure \n\n3f\n).",
    "figure_references": [
      {
        "figure_number": "Figure 3",
        "panel": "Panel f",
        "figure_key": "figure_3"
      }
    ]
  },
  {
    "sentence": "Indeed, LY75 expression increased when ESR1 was knocked down (Figure \n\n3g\n).",
    "figure_references": [
      {
        "figure_number": "Figure 3",
        "panel": "Panel g",
        "figure_key": "figure_3"
      }
    ]
  },
  {
    "sentence": "Finally, to determine whether the differences in binding shown in Figure \n\n3f\n might have functional consequences; we created reporter gene constructs that included ~ 1.1 kb of the LY75 promoter with WT and variant genotypes for the rs1877193 SNP.",
    "figure_references": [
      {
        "figure_number": "Figure 3",
        "panel": "Panel f",
        "figure_key": "figure_3"
      }
    ]
  },
  {
    "sentence": "However, when the cells were incubated with the addition of 100 nM anastrozole, the transcriptional activity in cells transfected with the variant SNP construct decreased (Figure \n\n3h–j\n).",
    "figure_references": [
      {
        "figure_number": "Figure 3",
        "panel": "Panel h",
        "figure_key": "figure_3"
      }
    ]
  },
  {
    "sentence": "We did not observe any change when we repeated the same experiments with exemestane (Figure \n\n3h–j\n).",
    "figure_references": [
      {
        "figure_number": "Figure 3",
        "panel": "Panel h",
        "figure_key": "figure_3"
      }
    ]
  },
  {
    "sentence": "To determine whether the SNP‐ and AI‐dependent LY75 gene regulation was mediated by ERα, we first identified two EREs; 2 bp overlap with each other) located ~ 200 bp distant from the LY75 SNP rs1877193 based on ENCODE data (Figure \n\n3e\n).",
    "figure_references": [
      {
        "figure_number": "Figure 3",
        "panel": "Panel e",
        "figure_key": "figure_3"
      }
    ]
  },
  {
    "sentence": "We then performed ChIP assays with ERα antibody and found that the rs1877193 SNP (Figure \n\n3f\n) showed striking differential binding to the ERE that was located closest to the SNP, with greater binding for the variant SNP genotype in the presence of androstenedione, but less binding when additional anastrozole was present.",
    "figure_references": [
      {
        "figure_number": "Figure 3",
        "panel": "Panel f",
        "figure_key": "figure_3"
      }
    ]
  },
  {
    "sentence": "However, this differential binding pattern was not detected after exemestane treatment (Figure \n\n3f\n).",
    "figure_references": [
      {
        "figure_number": "Figure 3",
        "panel": "Panel f",
        "figure_key": "figure_3"
      }
    ]
  },
  {
    "sentence": "Indeed, LY75 expression increased when ESR1 was knocked down (Figure \n\n3g\n).",
    "figure_references": [
      {
        "figure_number": "Figure 3",
        "panel": "Panel g",
        "figure_key": "figure_3"
      }
    ]
  },
  {
    "sentence": "Finally, to determine whether the differences in binding shown in Figure \n\n3f\n might have functional consequences; we created reporter gene constructs that included ~ 1.1 kb of the LY75 promoter with WT and variant genotypes for the rs1877193 SNP.",
    "figure_references": [
      {
        "figure_number": "Figure 3",
        "panel": "Panel f",
        "figure_key": "figure_3"
      }
    ]
  },
  {
    "sentence": "However, when the cells were incubated with the addition of 100 nM anastrozole, the transcriptional activity in cells transfected with the variant SNP construct decreased (Figure \n\n3h–j\n).",
    "figure_references": [
      {
        "figure_number": "Figure 3",
        "panel": "Panel h",
        "figure_key": "figure_3"
      }
    ]
  },
  {
    "sentence": "We did not observe any change when we repeated the same experiments with exemestane (Figure \n\n3h–j\n).",
    "figure_references": [
      {
        "figure_number": "Figure 3",
        "panel": "Panel h",
        "figure_key": "figure_3"
      }
    ]
  },
  {
    "sentence": "After filtering the co‐expression gene prediction results, 2,352 predicted genes (Figure \n\n4a\n) with Spearman’s correlations ≥ 0.3 or ≤ −0.3 were selected (Table \n\nS6\n).",
    "figure_references": [
      {
        "figure_number": "Figure 4",
        "panel": "Panel a",
        "figure_key": "figure_4"
      }
    ]
  },
  {
    "sentence": "Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway analysis of these 2,352 genes identified PI3K‐AKT, MAPK, cell adhesion, and JAK‐STAT pathways (Figure \n\n4b\n).",
    "figure_references": [
      {
        "figure_number": "Figure 4",
        "panel": "Panel b",
        "figure_key": "figure_4"
      }
    ]
  },
  {
    "sentence": "We evaluated the top pathways, and our results revealed that JAK/STAT signaling was dysregulated by LY75 depletion (Figure \n\n4c\n).",
    "figure_references": [
      {
        "figure_number": "Figure 4",
        "panel": "Panel c",
        "figure_key": "figure_4"
      }
    ]
  },
  {
    "sentence": "34\n, \n35\n, \n36\n, \n37\n Remarkably, LY75 suppression induced EMT as shown by the expression of specific EMT markers: a significant decrease of E‐cadherin and EPCAM; an increase of N‐cadherin and SNAIL1 (Figure \n\n4c\n).",
    "figure_references": [
      {
        "figure_number": "Figure 4",
        "panel": "Panel c",
        "figure_key": "figure_4"
      }
    ]
  },
  {
    "sentence": "LY75 knockdown cells also displayed decreased proliferation rates compared with the control (Figure \n\n2b\n), which was associated with decreased AKT and MAPK phosphorylation (Figure \n\n4c\n).",
    "figure_references": [
      {
        "figure_number": "Figure 2",
        "panel": "Panel b",
        "figure_key": "figure_2"
      },
      {
        "figure_number": "Figure 4",
        "panel": "Panel c",
        "figure_key": "figure_4"
      }
    ]
  },
  {
    "sentence": "Moreover, LY75 suppression significantly promoted cell migration (Figure \n\n4d\n).",
    "figure_references": [
      {
        "figure_number": "Figure 4",
        "panel": "Panel d",
        "figure_key": "figure_4"
      }
    ]
  },
  {
    "sentence": "Importantly, the addition of anastrozole, but not exemestane, significantly reduced the pSTAT3 and pERK levels in variant cells (Figure \n\n4e\n).",
    "figure_references": [
      {
        "figure_number": "Figure 4",
        "panel": "Panel e",
        "figure_key": "figure_4"
      }
    ]
  },
  {
    "sentence": "After filtering the co‐expression gene prediction results, 2,352 predicted genes (Figure \n\n4a\n) with Spearman’s correlations ≥ 0.3 or ≤ −0.3 were selected (Table \n\nS6\n).",
    "figure_references": [
      {
        "figure_number": "Figure 4",
        "panel": "Panel a",
        "figure_key": "figure_4"
      }
    ]
  },
  {
    "sentence": "Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway analysis of these 2,352 genes identified PI3K‐AKT, MAPK, cell adhesion, and JAK‐STAT pathways (Figure \n\n4b\n).",
    "figure_references": [
      {
        "figure_number": "Figure 4",
        "panel": "Panel b",
        "figure_key": "figure_4"
      }
    ]
  },
  {
    "sentence": "We evaluated the top pathways, and our results revealed that JAK/STAT signaling was dysregulated by LY75 depletion (Figure \n\n4c\n).",
    "figure_references": [
      {
        "figure_number": "Figure 4",
        "panel": "Panel c",
        "figure_key": "figure_4"
      }
    ]
  },
  {
    "sentence": "34\n, \n35\n, \n36\n, \n37\n Remarkably, LY75 suppression induced EMT as shown by the expression of specific EMT markers: a significant decrease of E‐cadherin and EPCAM; an increase of N‐cadherin and SNAIL1 (Figure \n\n4c\n).",
    "figure_references": [
      {
        "figure_number": "Figure 4",
        "panel": "Panel c",
        "figure_key": "figure_4"
      }
    ]
  },
  {
    "sentence": "LY75 knockdown cells also displayed decreased proliferation rates compared with the control (Figure \n\n2b\n), which was associated with decreased AKT and MAPK phosphorylation (Figure \n\n4c\n).",
    "figure_references": [
      {
        "figure_number": "Figure 2",
        "panel": "Panel b",
        "figure_key": "figure_2"
      },
      {
        "figure_number": "Figure 4",
        "panel": "Panel c",
        "figure_key": "figure_4"
      }
    ]
  },
  {
    "sentence": "Moreover, LY75 suppression significantly promoted cell migration (Figure \n\n4d\n).",
    "figure_references": [
      {
        "figure_number": "Figure 4",
        "panel": "Panel d",
        "figure_key": "figure_4"
      }
    ]
  },
  {
    "sentence": "Importantly, the addition of anastrozole, but not exemestane, significantly reduced the pSTAT3 and pERK levels in variant cells (Figure \n\n4e\n).",
    "figure_references": [
      {
        "figure_number": "Figure 4",
        "panel": "Panel e",
        "figure_key": "figure_4"
      }
    ]
  },
  {
    "sentence": "The GPR160 SNP rs62293499 (Figure \n\n5a\n) variant allele was associated with longer BCFI after treatment with exemestane as compared to anastrozole (Table \n\nS5\n).",
    "figure_references": [
      {
        "figure_number": "Figure 5",
        "panel": "Panel a",
        "figure_key": "figure_5"
      }
    ]
  },
  {
    "sentence": "GPR160 mRNA expression was induced by exposure to increasing concentrations of androstenedione in cells with WT genotype, but not in those with the variant SNP genotype (Figure \n\n5b\n).",
    "figure_references": [
      {
        "figure_number": "Figure 5",
        "panel": "Panel b",
        "figure_key": "figure_5"
      }
    ]
  },
  {
    "sentence": "We observed a striking reversal of expression with anastrozole, but not exemestane, that is, increased expression in the presence of anastrozole in cells with variant GPR160 SNP genotype, but decreased expression in cells with WT genotype (Figure \n\n5b\n).",
    "figure_references": [
      {
        "figure_number": "Figure 5",
        "panel": "Panel b",
        "figure_key": "figure_5"
      }
    ]
  },
  {
    "sentence": "Several EREs were located within 500 bp of the GPR160 SNP (Figure \n\n5c\n), and the rs62293499 SNP genotype was associated with striking differential binding to the EREs, with more binding for the WT SNP genotype in the presence of androstenedione, but a greater binding for the variant SNP when anastrozole was present.",
    "figure_references": [
      {
        "figure_number": "Figure 5",
        "panel": "Panel c",
        "figure_key": "figure_5"
      }
    ]
  },
  {
    "sentence": "Exemestane, however, did not change the binding activity (Figure \n\n5d\n).",
    "figure_references": [
      {
        "figure_number": "Figure 5",
        "panel": "Panel d",
        "figure_key": "figure_5"
      }
    ]
  },
  {
    "sentence": "In the present investigation, we evaluated the interaction between genetic variation and 2 AIs, exemestane and anastrozole, on BCFI in the MA.27 clinical trial in which postmenopausal women with resected early‐stage breast cancer were treated with anastrozole or exemestane adjuvant therapy (Figure \n\n1a\n).",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "Panel a",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "The SNPs identified in the interaction analysis were analyzed for their association with BCFI in the treatment‐specific cohort (Figure \n\n1b,c\n), as well as in the combined cohort using our pervious GWAS results.",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "Panel b",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "14\n This approach allowed the identification of genetic variants that have a differential effect on BCFI between the two AIs (Figure \n\n1d\n).",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "Panel d",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "The SNPs that interacted with treatments were otherwise lost in the BCFI analysis when the GWAS was adjusted for the treatment arms (Figure \n\n1e\n, Table \n\nS2\n).",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "Panel e",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "We identified an SNP‐based model (Table \n\nS3\n, Figure \n\n1f\n) as a biomarker signature panel for predicting superiority in efficacy between anastrozole and exemestane in a given patient.",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "Panel f",
        "figure_key": "figure_1"
      }
    ]
  }
]